Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2B, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized Dehydrated Human Amnion Chorion Membrane Injection as Compared to Saline Placebo Injection in the Treatment of Osteoarthritis of the Knee

NCT03485157 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.

NCT NCT03485157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03485157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2B, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized Dehydrated Human Amnion Chorion Membrane Injection as Compared to Saline Placebo Injection in the Treatment of Osteoarthritis of the Knee
Lead sponsor
MiMedx Group, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 27, 2018
Completion date
April 19, 2022
Enrollment
447 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis